News – Page 391 – Endpoints News

Martin Shkreli is back in the crosshairs of the federal government for not staying out of pharma

3 years ago

How small can you ‘omic? New startup wants to profile the tiny space between neurons to study Alzheimer’s

3 years ago

FDA lifts clinical hold on Astellas’ Pompe gene therapy

3 years ago

Seagen's Tukysa label expanded; ADARx gets $46M script for RNA trial

3 years ago

Sesen takes next step after investor attack, calls for shareholder vote to approve merger

3 years ago

Ipsen's pancreatic cancer drug bests decade-old standard of care

3 years ago

Disc Medicine pays $10M upfront for monoclonal antibody for rare blood disorder, cancer

3 years ago

As monotherapy data disappoint, Cyteir lets go of 35 staffers, goes all in on ovarian cancer

3 years ago

Scoop: Just months after Sanofi AI deal, Atomwise laid off 30% of staffers amid 'strategic shift'

3 years ago

#JPM23 with Robert Nelsen: Our motto is 'do cool s@*t'

3 years ago

'Perfect time': SIGA's CEO on retirement; Juvenescence woos GSK vet to lead anti-aging play

3 years ago

BeiGene's Brukinsa wins CLL approval after topping Imbruvica in head-to-head trial

3 years ago

FDA squashes accelerated hopes for Eli Lilly’s Alzheimer’s drug as agency asks for more data

3 years ago

Urovant taps celebrity advocate and patient Holly Robinson Peete for overactive bladder education

3 years ago

New clinical trial system to soon become mandatory in Europe

3 years ago

Manufacturing roundup: FDA, Swissmedic ink deal on pharma GMP; SK biotech contracts with Charles River for RNA ...

3 years ago

Small-cap CNS outfit inks API deal for preclinical MEK inhibitor

3 years ago

Intas Pharmaceuticals under FDA scrutiny over 'cascade of failure' in oversight of GMP documents

3 years ago

In bid to advance manufacturing capabilities, Inscripta buys out two biotechs

3 years ago

Genentech touts positive Phase III data for Tecentriq/Avastin combo in liver cancer

3 years ago

Rep. Frank Pallone wants FDA and NIH to act on pharma's noncompliance with trial records law

3 years ago

After hypertension competitor gets bought, Mineralys lines up IPO plans

3 years ago

Caris gets $400M loan from OrbiMed and Braidwell; bluebird stock sales brings in $120M

3 years ago

Amarin, Sarissa continue playing out activist attack

3 years ago

First page Previous page 388 389 390391392 393 394 Next page Last page